From: DNA methylation alterations across time and space in paediatric brain tumours
Patient ID | Primary PAD | Relapse PAD | Primary methylation class | Relapse methylation class |
---|---|---|---|---|
pTT-6 | PA grade I | DLGNT | Supratentorial midline PA (0.74) | Supratentorial midline PA (0.82) |
pTT-9 | Malignant glioneural tumour | Anaplastic EPN grade III | Supratentorial EPN, ZFTA:RELA fusion-positive (0.99) | Supratentorial EPN, ZFTA:RELA fusion-positive (0.99) |
pTT-19 | Ganglioglioma | Ganglioglioma | Supratentorial PA (0.24) | Ganglioglioma (0.92) |
pTT-21 | PA grade I | Malignant high-grade tumour | Neuroepithelial tumour with PATZ1 fusion (0.99) | Neuroepithelial tumour with PATZ1 fusion (0.97) |
pTT-23 | High-grade primitive tumour | Malignant-high grade tumour | No class | No class |
pTT-28 | PA grade I | PA grade I | Supratentorial midline PA (0.71) | PXA(-like) (0.98) |
pTT-32 | Glioblastoma | Malignant high-grade tumour | Diffuse paediatric-type high grade glioma, MYCN subtype (0.11) | Supratentorial EPN, ZFTA:RELA fusion-positive (0.26) |